(19)
(11) EP 4 739 351 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24836564.5

(22) Date of filing: 03.07.2024
(51) International Patent Classification (IPC): 
A61K 48/00(2006.01)
A61P 9/04(2006.01)
C12N 15/864(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 9/04; C12N 15/86; C12N 2750/14143; C12N 9/1205; A01K 67/0275; A01K 2217/075; A01K 2227/105; A01K 2267/0375; A61K 48/005; A01K 2217/072; A61K 38/45; C12Y 207/11001
(86) International application number:
PCT/US2024/036646
(87) International publication number:
WO 2025/010312 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 06.07.2023 US 202363512200 P

(71) Applicant: The Regents of the University of California
Oakland, CA 94607-5200 (US)

(72) Inventors:
  • CHEN, Ju
    San Diego, California 92129 (US)
  • FENG, Wei
    San Diego, California 92131 (US)

(74) Representative: Berggren Oy 
P.O. Box 16 Fabianinkatu 21
00101 Helsinki
00101 Helsinki (FI)

   


(54) GENE REPLACEMENT THERAPY FOR ALPK3 CARDIOMYOPATHY